{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:32:37Z","timestamp":1792704757038,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["grant 82072641"],"award-info":[{"award-number":["grant 82072641"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-024-55769-8","type":"journal-article","created":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:50:14Z","timestamp":1735865414000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Positive feedback between arginine methylation of YAP and methionine transporter SLC43A2 drives anticancer drug resistance"],"prefix":"10.1038","volume":"16","author":[{"given":"Xia-Lu","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Kai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Hong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan-Yu","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Qing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Han","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7137-112X","authenticated-orcid":false,"given":"Wei-Fen","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,2]]},"reference":[{"key":"55769_CR1","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13034","volume":"18","author":"AA Parkhitko","year":"2019","unstructured":"Parkhitko, A. A., Jouandin, P., Mohr, S. E. & Perrimon, N. Methionine metabolism and methyltransferases in the regulation of aging and lifespan extension across species. Aging Cell 18, e13034 (2019).","journal-title":"Aging Cell"},{"key":"55769_CR2","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41392-020-00349-7","volume":"5","author":"Z Li","year":"2020","unstructured":"Li, Z. et al. Methionine metabolism in chronic liver diseases: an update on molecular mechanism and therapeutic implication. Signal Transduct. Target Ther. 5, 280 (2020).","journal-title":"Signal Transduct. Target Ther."},{"key":"55769_CR3","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/s41568-019-0187-8","volume":"19","author":"SM Sanderson","year":"2019","unstructured":"Sanderson, S. M., Gao, X., Dai, Z. & Locasale, J. W. Methionine metabolism in health and cancer: a nexus of diet and precision medicine. Nat. Rev. Cancer 19, 625\u2013637 (2019).","journal-title":"Nat. Rev. Cancer"},{"key":"55769_CR4","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1182\/blood.2022017575","volume":"140","author":"A Cunningham","year":"2022","unstructured":"Cunningham, A. et al. Dietary methionine starvation impairs acute myeloid leukemia progression. Blood 140, 2037\u20132052 (2022).","journal-title":"Blood"},{"key":"55769_CR5","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/s41586-019-1437-3","volume":"572","author":"X Gao","year":"2019","unstructured":"Gao, X. et al. Dietary methionine influences therapy in mouse cancer models and alters human metabolism. Nature 572, 397\u2013401 (2019).","journal-title":"Nature"},{"key":"55769_CR6","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.ccell.2023.05.005","volume":"41","author":"L Fang","year":"2023","unstructured":"Fang, L. et al. Methionine restriction promotes cGAS activation and chromatin untethering through demethylation to enhance antitumor immunity. Cancer Cell 41, 1118\u20131133.e1112 (2023).","journal-title":"Cancer Cell"},{"key":"55769_CR7","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1136\/gutjnl-2022-326928","volume":"72","author":"T Li","year":"2023","unstructured":"Li, T. et al. Methionine deficiency facilitates antitumour immunity by altering m6A methylation of immune checkpoint transcripts. Gut 72, 501\u2013511 (2023).","journal-title":"Gut"},{"key":"55769_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40518-0","volume":"14","author":"Y Xue","year":"2023","unstructured":"Xue, Y. et al. Intermittent dietary methionine deprivation facilitates tumoral ferroptosis and synergizes with checkpoint blockade. Nat. Commun. 14, 4758 (2023).","journal-title":"Nat. Commun."},{"key":"55769_CR9","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41392-023-01341-7","volume":"8","author":"N Wang","year":"2023","unstructured":"Wang, N., Ma, T. & Yu, B. Targeting epigenetic regulators to overcome drug resistance in cancers. Signal Transduct. Target Ther. 8, 69 (2023).","journal-title":"Signal Transduct. Target Ther."},{"key":"55769_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01782-2","volume":"22","author":"H Zhuang","year":"2023","unstructured":"Zhuang, H. et al. The role of m6A methylation in therapy resistance in cancer. Mol. Cancer 22, 91 (2023).","journal-title":"Mol. Cancer"},{"key":"55769_CR11","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/nrgastro.2016.59","volume":"13","author":"AW Hong","year":"2016","unstructured":"Hong, A. W., Meng, Z. & Guan, K.-L. The Hippo pathway in intestinal regeneration and disease. Nat. Rev. Gastroenterol. Hepatol. 13, 324\u2013337 (2016).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"55769_CR12","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/s41392-022-01191-9","volume":"7","author":"M Fu","year":"2022","unstructured":"Fu, M. et al. The Hippo signalling pathway and its implications in human health and diseases. Signal Transduct. Target Ther. 7, 376 (2022).","journal-title":"Signal Transduct. Target Ther."},{"key":"55769_CR13","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1038\/onc.2015.219","volume":"35","author":"E Ciamporcero","year":"2015","unstructured":"Ciamporcero, E. et al. YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage. Oncogene 35, 1541\u20131553 (2015).","journal-title":"Oncogene"},{"key":"55769_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01676-9","volume":"21","author":"MER Garcia-Rendueles","year":"2022","unstructured":"Garcia-Rendueles, M. E. R. et al. Yap governs a lineage-specific neuregulin1 pathway-driven adaptive resistance to RAF kinase inhibitors. Mol. Cancer 21, 213 (2022).","journal-title":"Mol. Cancer"},{"key":"55769_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05919-5","volume":"14","author":"Y-C Yan","year":"2023","unstructured":"Yan, Y.-C. et al. Diacylglycerol lipase alpha promotes hepatocellular carcinoma progression and induces lenvatinib resistance by enhancing YAP activity. Cell Death Dis. 14, 404 (2023).","journal-title":"Cell Death Dis."},{"key":"55769_CR16","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ccell.2018.06.002","volume":"34","author":"L Fang","year":"2018","unstructured":"Fang, L. et al. SET1A-mediated mono-methylation at K342 regulates YAP activation by blocking its nuclear export and promotes tumorigenesis. Cancer Cell 34, 103\u2013118.e109 (2018).","journal-title":"Cancer Cell"},{"key":"55769_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118406","volume":"260","author":"J Wu","year":"2020","unstructured":"Wu, J., Chai, H., Li, F., Ren, Q. & Gu, Y. SETD1A augments sorafenib primary resistance via activating YAP in hepatocellular carcinoma. Life Sci. 260, 118406 (2020).","journal-title":"Life Sci."},{"key":"55769_CR18","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.devcel.2013.05.025","volume":"26","author":"MJ Oudhoff","year":"2013","unstructured":"Oudhoff, M. J. et al. Control of the Hippo pathway by set7-dependent methylation of Yap. Dev. Cell 26, 188\u2013194 (2013).","journal-title":"Dev. Cell"},{"key":"55769_CR19","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41392-024-01805-4","volume":"9","author":"H Qian","year":"2024","unstructured":"Qian, H. et al. SRY-Box transcription factor 9 triggers YAP nuclear entry via direct interaction in tumors. Signal Transduct. Target Ther. 9, 96 (2024).","journal-title":"Signal Transduct. Target Ther."},{"key":"55769_CR20","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.cmet.2018.07.010","volume":"28","author":"JH Koo","year":"2018","unstructured":"Koo, J. H. & Guan, K.-L. Interplay between YAP\/TAZ and Metabolism. Cell Metab. 28, 196\u2013206 (2018).","journal-title":"Cell Metab."},{"key":"55769_CR21","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.7150\/thno.32915","volume":"9","author":"C-C Kuo","year":"2019","unstructured":"Kuo, C.-C. et al. Metastatic colorectal cancer rewrites metabolic program through a Glut3-YAP-dependent signaling circuit. Theranostics 9, 2526\u20132540 (2019).","journal-title":"Theranostics"},{"key":"55769_CR22","doi-asserted-by":"publisher","first-page":"e383","DOI":"10.1038\/oncsis.2017.83","volume":"6","author":"Y Gao","year":"2017","unstructured":"Gao, Y. et al. TNF\u03b1-YAP\/p65-HK2 axis mediates breast cancer cell migration. Oncogenesis 6, e383\u2013e383 (2017).","journal-title":"Oncogenesis"},{"key":"55769_CR23","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s10456-020-09760-8","volume":"24","author":"Y Feng","year":"2021","unstructured":"Feng, Y. et al. YAP promotes ocular neovascularization by modifying PFKFB3-driven endothelial glycolysis. Angiogenesis 24, 489\u2013504 (2021).","journal-title":"Angiogenesis"},{"key":"55769_CR24","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1172\/JCI86387","volume":"126","author":"T Bertero","year":"2016","unstructured":"Bertero, T. et al. Vascular stiffness mechanoactivates YAP\/TAZ-dependent glutaminolysis to drive pulmonary hypertension. J. Clin. Invest 126, 3313\u20133335 (2016).","journal-title":"J. Clin. Invest"},{"key":"55769_CR25","doi-asserted-by":"crossref","unstructured":"Edwards, D. N. et al. The receptor tyrosine kinase EphA2 promotes glutamine metabolism in tumors by activating the transcriptional coactivators YAP and TAZ. Sci. Signal. 10, eaan4667 (2017).","DOI":"10.1126\/scisignal.aan4667"},{"key":"55769_CR26","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/hep.28223","volume":"63","author":"YY Park","year":"2015","unstructured":"Park, Y. Y. et al. Yes\u2010associated protein 1 and transcriptional coactivator with PDZ\u2010binding motif activate the mammalian target of rapamycin complex 1 pathway by regulating amino acid transporters in hepatocellular carcinoma. Hepatology 63, 159\u2013172 (2015).","journal-title":"Hepatology"},{"key":"55769_CR27","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/s41556-022-00848-5","volume":"24","author":"H Li","year":"2022","unstructured":"Li, H. et al. YAP\/TAZ drives cell proliferation and tumour growth via a polyamine\u2013eIF5A hypusination\u2013LSD1 axis. Nat. Cell Biol. 24, 373\u2013383 (2022).","journal-title":"Nat. Cell Biol."},{"key":"55769_CR28","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1016\/j.molcel.2021.04.009","volume":"81","author":"Q Pan","year":"2021","unstructured":"Pan, Q. et al. The ZMYND8-regulated mevalonate pathway endows YAP-high intestinal cancer with metabolic vulnerability. Mol. Cell 81, 2736\u20132751.e2738 (2021).","journal-title":"Mol. Cell"},{"key":"55769_CR29","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.devcel.2019.07.022","volume":"51","author":"S Murakami","year":"2019","unstructured":"Murakami, S. et al. A Yap-Myc-Sox2-p53 regulatory network dictates metabolic homeostasis and differentiation in Kras-driven pancreatic ductal adenocarcinomas. Dev. Cell 51, 113\u2013128.e119 (2019).","journal-title":"Dev. Cell"},{"key":"55769_CR30","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.trecan.2019.02.010","volume":"5","author":"CDK Nguyen","year":"2019","unstructured":"Nguyen, C. D. K. & Yi, C. YAP\/TAZ signaling and resistance to cancer therapy. Trends Cancer 5, 283\u2013296 (2019).","journal-title":"Trends Cancer"},{"key":"55769_CR31","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.add3339","volume":"8","author":"Z Zhao","year":"2022","unstructured":"Zhao, Z. et al. CARM1-mediated methylation of ASXL2 impairs tumor-suppressive function of MLL3\/COMPASS. Sci. Adv. 8, eadd3339 (2022).","journal-title":"Sci. Adv."},{"key":"55769_CR32","doi-asserted-by":"publisher","first-page":"5496","DOI":"10.1074\/jbc.M709037200","volume":"283","author":"Y Hao","year":"2008","unstructured":"Hao, Y., Chun, A., Cheung, K., Rashidi, B. & Yang, X. Tumor suppressor LATS1 is a negative regulator of oncogene YAP. J. Biol. Chem. 283, 5496\u20135509 (2008).","journal-title":"J. Biol. Chem."},{"key":"55769_CR33","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1101\/gad.1664408","volume":"22","author":"B Zhao","year":"2008","unstructured":"Zhao, B. et al. TEAD mediates YAP-dependent gene induction and growth control. Genes Dev. 22, 1962\u20131971 (2008).","journal-title":"Genes Dev."},{"key":"55769_CR34","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41586-020-2682-1","volume":"585","author":"Y Bian","year":"2020","unstructured":"Bian, Y. et al. Cancer SLC43A2 alters T cell methionine metabolism and histone methylation. Nature 585, 277\u2013282 (2020).","journal-title":"Nature"},{"key":"55769_CR35","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/s41591-019-0423-5","volume":"25","author":"Z Wang","year":"2019","unstructured":"Wang, Z. et al. Methionine is a metabolic dependency of tumor-initiating cells. Nat. Med. 25, 825\u2013837 (2019).","journal-title":"Nat. Med."},{"key":"55769_CR36","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s13402-021-00595-z","volume":"44","author":"T Sun","year":"2021","unstructured":"Sun, T., Mao, W., Peng, H., Wang, Q. & Jiao, L. YAP promotes sorafenib resistance in hepatocellular carcinoma by upregulating survivin. Cell Oncol. 44, 689\u2013699 (2021).","journal-title":"Cell Oncol."},{"key":"55769_CR37","doi-asserted-by":"publisher","first-page":"5794","DOI":"10.7150\/thno.56604","volume":"11","author":"Q Li","year":"2021","unstructured":"Li, Q. et al. MYBL2 disrupts the Hippo-YAP pathway and confers castration resistance and metastatic potential in prostate cancer. Theranostics 11, 5794\u20135812 (2021).","journal-title":"Theranostics"},{"key":"55769_CR38","doi-asserted-by":"crossref","unstructured":"Yang, C. S. et al. Glutamine\u2010utilizing transaminases are a metabolic vulnerability of TAZ\/YAP\u2010activated cancer cells. EMBO Rep. 19, e43577 (2018).","DOI":"10.15252\/embr.201643577"},{"key":"55769_CR39","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1038\/cr.2015.140","volume":"25","author":"CG Hansen","year":"2015","unstructured":"Hansen, C. G., Ng, Y. L. D., Lam, W.-L. M., Plouffe, S. W. & Guan, K.-L. The Hippo pathway effectors YAP and TAZ promote cell growth by modulating amino acid signaling to mTORC1. Cell Res. 25, 1299\u20131313 (2015).","journal-title":"Cell Res."},{"key":"55769_CR40","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/s42255-022-00584-y","volume":"4","author":"YT Ong","year":"2022","unstructured":"Ong, Y. T. et al. A YAP\/TAZ-TEAD signalling module links endothelial nutrient acquisition to angiogenic growth. Nat. Metab. 4, 672\u2013682 (2022).","journal-title":"Nat. Metab."},{"key":"55769_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38316-9","volume":"14","author":"M Pandit","year":"2023","unstructured":"Pandit, M. et al. Methionine consumption by cancer cells drives a progressive upregulation of PD-1 expression in CD4 T cells. Nat. Commun. 14, 2593 (2023).","journal-title":"Nat. Commun."},{"key":"55769_CR42","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.molcel.2020.09.006","volume":"80","author":"W Wang","year":"2020","unstructured":"Wang, W. & Zou, W. Amino acids and their transporters in T cell immunity and cancer therapy. Mol. Cell 80, 384\u2013395 (2020).","journal-title":"Mol. Cell"},{"key":"55769_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40345-3","volume":"14","author":"Y Huang","year":"2023","unstructured":"Huang, Y. et al. A bimetallic nanoplatform for STING activation and CRISPR\/Cas mediated depletion of the methionine transporter in cancer cells restores anti-tumor immune responses. Nat. Commun. 14, 4647 (2023).","journal-title":"Nat. Commun."},{"key":"55769_CR44","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1158\/0008-5472.CAN-20-1323","volume":"81","author":"L-Y Cai","year":"2021","unstructured":"Cai, L.-Y. et al. Targeting p300\/CBP attenuates hepatocellular carcinoma progression through epigenetic regulation of metabolism. Cancer Res. 81, 860\u2013872 (2021).","journal-title":"Cancer Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-55769-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-55769-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-55769-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T01:11:35Z","timestamp":1735866695000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-55769-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,2]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["55769"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-55769-8","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,2]]},"assertion":[{"value":"25 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"87"}}